Valuation: Tasly Pharmaceutical Group Co., Ltd

Market Cap 20.65B 3.1B 2.78B 2.56B 2.32B 4.33B 295B 4.41B 30.47B 12.23B 155B 11.64B 11.39B 489B P/E 2026 *
16.5x
P/E 2027 * 13.3x
Enterprise Value 19.1B 2.87B 2.57B 2.36B 2.14B 4B 273B 4.08B 28.2B 11.32B 143B 10.77B 10.54B 452B EV / Sales 2026 *
2.23x
EV / Sales 2027 * 1.61x
Free-Float
47.11%
Yield 2026 *
2.52%
Yield 2027 * 3.31%
1 day+1.54%
1 week+0.29%
1 month-1.29%
3 months-14.27%
6 months-8.66%
Current year-8.29%
1 week 13.48
Extreme 13.48
14.05
1 month 13.48
Extreme 13.48
14.44
Current year 12.9
Extreme 12.9
16.24
1 year 12.9
Extreme 12.9
16.24
3 years 12.24
Extreme 12.24
18
5 years 9.2
Extreme 9.2
18
10 years 9.2
Extreme 9.2
34.22
Manager TitleAgeSince
Chief Executive Officer 54 2024-05-07
Director of Finance/CFO 49 2018-07-08
Chief Investment Officer 45 2025-04-30
Director TitleAgeSince
Director/Board Member 72 2021-06-01
Chairman 54 2026-08-09
Director/Board Member 59 2024-05-07
Change 5-day change 1-year change 3-year change Capi.($)
+1.54%+0.29%-10.55%-7.37% 3.1B
+3.19%+11.31%+64.28%+155.66% 1,263B
-0.73%+3.56%+44.65%+83.74% 658B
+1.41%+3.24%+35.25%+106.98% 521B
+0.42%+3.20%+55.81%+69.71% 391B
+2.18%+2.93%+73.90%+45.38% 369B
+1.12%+4.52%+34.76%+57.00% 307B
+6.96%+8.86%+11.95%+35.06% 290B
+1.15%+6.09%+56.15%+78.66% 252B
+3.06%+9.38%+42.48%+112.84% 212B
Average +2.03%+5.22%+40.87%+73.77% 426.5B
Weighted average by Cap. +2.01%+6.59%+50.46%+99.11%

Financials

2026 *2027 *
Net sales 8.58B 1.29B 1.15B 1.06B 962M 1.8B 122B 1.83B 12.66B 5.08B 64.36B 4.84B 4.73B 203B 9.27B 1.39B 1.25B 1.15B 1.04B 1.94B 132B 1.98B 13.68B 5.49B 69.58B 5.23B 5.12B 219B
Net income 1.25B 188M 169M 155M 141M 263M 17.89B 268M 1.85B 743M 9.41B 707M 692M 29.67B 1.56B 234M 210M 193M 175M 327M 22.22B 333M 2.3B 923M 11.69B 878M 860M 36.86B
Net Debt -1.54B -232M -208M -191M -173M -324M -22.03B -330M -2.28B -915M -11.59B -871M -852M -36.54B -5.71B -858M -769M -707M -641M -1.2B -81.49B -1.22B -8.43B -3.38B -42.87B -3.22B -3.15B -135B
Projected Income Statement - Annual - Tasly Pharmaceutical Group Co., Ltd
Logo Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co Ltd is a China-based company principally engaged in the manufacture and distribution of pharmaceutical products. The Company's main businesses include the manufacture and sales of traditional Chinese medicines, chemical preparations, chemical raw materials and biological medicines. The Company's main products include Compound Danshen Dropping Pills, Yangxuenao Granules, Yangxuenao Pills, Qishen Yiqi Dropping Pills, Diqing and Shuilinjia. Its products are used to treat cardiovascular and cerebrovascular diseases, tumors, colds, fevers and liver diseases. The Company mainly distributes its products in the domestic market.
Employees
10,563
Date Price Change Volume
26-10-30 CN¥13.82 +1.54% 13,316,949
26-10-29 CN¥13.61 -0.51% 9,923,400
26-10-28 CN¥13.68 -0.15% 11,892,180
26-10-27 CN¥13.70 -1.79% 12,568,160
26-10-26 CN¥13.95 +1.23% 16,264,276
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Tasly Pharmaceutical Group Co., Ltd
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
13.82CNY
Average target price
16.89CNY
Spread / Average Target
+22.23%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Tasly Pharmaceutical Group Co., Ltd
  1. Stock Market
  2. Stocks
  3. 600535 Stock